Surgical Robotics Market (By Component: Systems, Accessories, Services; By Surgery Type: Gynecology Surgery, Urology Surgery, Neurosurgery, Orthopedic Surgery, General Surgery, Other Surgeries; By End User: Hospitals, Ambulatory surgical centers )- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Surgical Robotics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Surgical Robotics Market, by Component, 2023-2032
8.1.1 Systems
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Accessories
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2021-2032)
9.1. Surgical Robotics Market, by Surgery Type, 2023-2032
9.1.1. Gynecology Surgery
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Urology Surgery
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Neurosurgery
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. Orthopedic Surgery
9.1.4.1. Market Revenue and Forecast (2021-2032)
9.1.5. General Surgery
9.1.5.1. Market Revenue and Forecast (2021-2032)
9.1.6. Other Surgeries
9.1.6.1. Market Revenue and Forecast (2021-2032)
10.1. Surgical Robotics Market, by End User, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Ambulatory surgical centers
10.1.2.1. Market Revenue and Forecast (2021-2032)
11.1. North America
11.1.1. Market Revenue and Forecast, by Component (2021-2032)
11.1.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.1.3. Market Revenue and Forecast, by End User (2021-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.1.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.1.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.1.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.1.5.3. Market Revenue and Forecast, by End User (2021-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component (2021-2032)
11.2.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.2.3. Market Revenue and Forecast, by End User (2021-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.2.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.2.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.2.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.2.5.3. Market Revenue and Forecast, by End User (2021-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component (2021-2032)
11.2.6.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.2.6.3. Market Revenue and Forecast, by End User (2021-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component (2021-2032)
11.2.7.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.2.7.3. Market Revenue and Forecast, by End User (2021-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component (2021-2032)
11.3.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.3.3. Market Revenue and Forecast, by End User (2021-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.3.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.3.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.3.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.3.5.3. Market Revenue and Forecast, by End User (2021-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component (2021-2032)
11.3.6.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.3.6.3. Market Revenue and Forecast, by End User (2021-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component (2021-2032)
11.3.7.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.3.7.3. Market Revenue and Forecast, by End User (2021-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.4.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.4.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.4.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.4.5.3. Market Revenue and Forecast, by End User (2021-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component (2021-2032)
11.4.6.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.4.6.3. Market Revenue and Forecast, by End User (2021-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component (2021-2032)
11.4.7.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.4.7.3. Market Revenue and Forecast, by End User (2021-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.5.3. Market Revenue and Forecast, by End User (2021-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.5.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.5.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.5.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.5.5.3. Market Revenue and Forecast, by End User (2021-2032)
12.1. Medrobotics
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Renishaw plc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. TransEnterix Surgical, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Intuitive Surgical
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Medtronic plc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. THINK Surgical Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Zimmer Biomet Holdings Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Smith & Nephew Plc. (Blue Belt Technologies, Inc.)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Auris Surgical Robotics, Inc. (Hansen Medical Inc.)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Intuitive Surgical, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample